GASCO's 2026 Annual Meeting and Best of ASCO®, including Administrators' Association & Business of Oncology Meeting and Cancer Patient Navigators of Georgia Tracks
Meeting Host
Georgia Society of Clinical Oncology
Access Meeting Documents
Description
Best of ASCO is a Program Licensed by the American Society of Clinical Oncology, Inc. and Jointly Provided by Postgraduate Institute for Medicine
The Georgia Society of Clinical Oncology (GASCO) invites oncology professionals from across Georgia and the Southeast to attend the 2026 GASCO Annual Meeting and Best of ASCO®.
This premier educational event features Innovative Pathways in Oncology: Diagnostics, Therapeutics and AI, highlighting advances in molecular diagnostics, antibody-drug conjugates (ADCs), cancer-associated thrombosis, and the growing role of artificial intelligence in oncology care. Attendees will also receive the latest practice-changing updates through GASCO's officially licensed Best of ASCO® program, featuring expert summaries of key research presented at the 2026 ASCO® Annual Meeting across multiple disease states.
The meeting also includes the Administration and Business of Oncology Meeting and the Cancer Patient Navigators of Georgia (CPNG) Navigation and Survivorship Track, providing valuable educational opportunities for the entire oncology care team.
Target Audience: Medical oncologists, hematologists, radiation oncologists, surgeons, advanced practice providers, pharmacists, nurses, patient navigators, social workers, oncology administrators, fellows, residents, researchers, and other healthcare professionals involved in cancer care.
Educational Objectives
After completing this activity, the participant should be better able to:
- Evaluate current evidence supporting new diagnostic and therapeutic approaches for major solid tumors and hematologic malignancies and determine how these findings should be incorporated into community oncology practice.
- Assess the appropriate clinical application of multicancer early detection testing, antibody-drug conjugates, and other emerging diagnostic and therapeutic innovations.
- Describe current evidence supporting the use of artificial intelligence in oncology and identify opportunities for responsible integration into clinical practice.
Agenda
- CPNG agenda – Friday
- Administration and Business of Oncology Meeting agenda – Friday
- GASCO Annual Meeting and Best of ASCO® – Friday
- GASCO Annual Meeting and Best of ASCO® – Saturday
When
Friday, August 21 — Saturday, August 22, 2026
Where
The Hotel at Avalon
9000 Avalon Boulevard
Alpharetta, Georgia 30009
Disclosure of Financial Relationships
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified financial relationships are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
| Speaker | Disclosure |
|---|---|
| Karen Beard, CPC, CPCO | No conflicts of interest disclosed. |
| Kevin Becker, MD, MMM |
(1) Grant/Research Support: Novartis, (ended: AstraZeneca, Eli Lilly, BeiGene) (2) Consultant/Advisory Board: Janssen (ended) |
| Sarah Brewer, MBA MHA | No conflicts of interest disclosed. |
| Jacqueline Brown, MD |
(1) Grant/Research Support: Medicenna, Pliant Therapeutics, Lilly, Merck, EvolveImmune, Astellas, Exelixis (2) Speakers Bureau/Honoraria for non-CME: DAVA Oncology, Curio Science, Cardinal Health (3) Consultant/Advisory Board: Pfizer |
| Debora Bruno, MD, MS | (1) Consultant/Advisory Board: AstraZeneca, Daiichi-Sankyo |
| Guilherme S.C. Correia, MD | (1) Consultant/Advisory Board: Pfizer |
| Crain Garrot, MD | No conflicts of interest disclosed. |
| Keerthi Gogineni, MD, MSHP |
(1) Employee/Owner: Pfizer, Calithera, Merck, Genentech, SeaGen, Metaclipse Therapeutics, Mayo, Briacell (2) Grant/Research Support: Calithera (ended) (3) Speakers Bureau/Honoraria for non-CME: AmerisourceBergen, OncLive, OncLive/MJH Life Sciences - Speaker Honoraria for CME (ended) (4) Consultant/Advisory Board: Pfizer (ended) |
| Caroline Hana, MD, MHPE | No conflicts of interest disclosed. |
| Lindsay Hannan, MD, MSc | No conflicts of interest disclosed. |
| Chirag Jani, MD | No conflicts of interest disclosed. |
| Larry Kessler, BS, ScD | No conflicts of interest disclosed. |
| Amany Keruakous, MD |
(1) Employee/Owner: Wellstar MCG, Georgia Cancer Center; (2) Grant/Research Support: Janssen Pharmaceutical Inc., Pfizer; (3) Speakers Bureau/Honoraria for non-CME: BMS, Pfizer, Decera, Regeneron (4) Consultant/Advisory Board: Janssen, Abbvie, BMS, PlatformQ, COO, KITE |
| Beryl Manning-Geist, MD |
(1) Employee/Owner: Emory University School of Medicine (2) Grant/Research Support: NIH (3) Consultant/Advisory Board: Verastem Pharmaceuticals, Eli Lilly, Incyte, Bio, Douglas & London, CARIS, Department of Defense |
| Eyal Meiri, MD | (1) Consultant/Advisory Board: Revolution Medicines, Astra Zeneca |
| Allyn Moushey | No conflicts of interest disclosed. |
| Ravi Parikh, MD, MPP |
(1) Employee/Owner: Emory University (2) Grant/Research Support: National Institutes of Health, Schmidt Futures, Arnold Ventures, Veterans Health Administration; Ended: Prostate Cancer Foundation, Humana, Emerson Collective, Mendel.ai (3) Consultant/Advisory Board: GNS Healthcare, Thyme Care, Main Street Health, Onc.AI, Cancer Study Group. Ended: ConcertAI, Mendel.ai, Optinosis, Biofourmis, Archetype Therapeutics, CreditSuisse, G1 Therapeutics, Humana, and Nanology (4) Non-Mutual Funds Stock Ownership/Stock Options: Counsel Health and Scaled Insights (5) Other financial or material support: Editor at Journal of Clinical Oncology |
| Girindra Raval, MD | (1) Speakers Bureau/Honoraria for non-CME: AstraZeneca, Sanofi |
| Priya Rudolph, MD, PhD |
(1) Speakers Bureau/Honoraria for non-CME: AstraZeneca, Daiichi Sankyo, Inc., Pfizer, Celcuity, Stemline, Gilead (2) Consultant/Advisory Board: Bristol Myers Squibb, Daiichi Sankyo, Inc, Pfizer, SERB Pharmaceuticals, PharmaEssentia, Gilead, Eli Lilly, Sanofi, Astra Zeneca, EMD Serono, Aurinia |
| Nate Wilson, MD | No conflicts of interest disclosed. |
| Amelia Zelnak, MD, MSc |
(1) Employee/Owner: Atlanta Cancer Care (2) Consultant/Advisory Board: Menarini-Stemline |
2026 CPNG Annual Meeting Speaker Disclosures
| Speaker | Disclosure |
|---|---|
| Cheryl Kirby, LCSW | No conflicts of interest disclosed. |
| Janae Finley, PT, DPT | No conflicts of interest disclosed. |
| Ariel Hornberger, ACSM-EP | No conflicts of interest disclosed. |
| Laura Karfeld, LCSW | No conflicts of interest disclosed. |
| Bryan Miller, LCSW | No conflicts of interest disclosed. |
| Christopher Maxwell, LCSW | No conflicts of interest disclosed. |
| Whitney Griggs, MPH | No conflicts of interest disclosed. |
| Natasha Taylor, MA | No conflicts of interest disclosed. |
| Emily Beard, RN | No conflicts of interest disclosed. |
| Fiona O'Carroll, J.D. | No conflicts of interest disclosed. |
The PIM planners and others have nothing to disclose. The Georgia Society of Clinical Oncology (GASCO) planners and others have nothing to disclose.
All relevant financial relationships have been mitigated.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Georgia Society of Clinical Oncology (GASCO). Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 10.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 13.25 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 10.25 contact hour(s) (1.0 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number -JA4008162-9999-26-567-L99-P) Type of Activity: Knowledge
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 3 clinical continuing education credits.
American Board of Internal Medicine (ABIM) Maintenance of Certification Program
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.25 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Americans with Disabilities Act (required for live meetings only)
Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact Anne Marie Cahill prior to the live event at 770-951-1018 or via email anne@gasco.us.
Fee Information
No fee for CME activity.
In order to obtain your CE certificate, please follow the steps below at the conclusion of the activity:
- Go to www.cmeuniversity.com
-
Login or Create a New Account (will take less than 1 minute)
- If you receive a message when creating a new account that "the email you entered is already in use", please click the forgot my username or password link to have your Username and Password sent to you via email
- After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
- Type in the credit claiming code at the top of the page, in the lefthand search bar, "Claim CME Credits: Post Test/Evaluation," then enter. The credit claiming code will be shared at the conference via a QR code in the agenda.
- Click on the activity title when it appears
- Choose the type of credit you desire
- Complete the online Evaluation
- Receive an immediate CE Certificate to download or print. The CE Certificate will be emailed to your address on file.
For Pharmacists: Credit claiming must be completed within 30 days of the conclusion of the event to be accepted by NABP. Upon successfully completing the post-test with a score of 75% or better (if applicable) and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service.
For Non-pharmacists: Credit claiming must be completed within 60 days of the conclusion of the event or by February 22nd, 2027. Upon successfully completing the post-test with a score of 75% or better (if applicable) and the activity evaluation form, you will be provided the opportunity to print or save your Certificate. Additionally your certificate will be sent via email and a copy retained in your CMEU Profile History.
If you have questions regarding the certification of this activity, please contact PIM via email at inquiries@pimed.com.
Hotel Accommodations - IMPORTANT UPDATE
The GASCO room block at The Hotel at Avalon has reached capacity and cannot be extended.
For attendees who have not yet secured hotel accommodations, GASCO has provided an alternate reservation link to assist you in locating available accommodations in the Avalon/Alpharetta area for the Annual Meeting.
Please note: Reservations made through this link are not part of the GASCO room block, and hotel availability and rates will vary.
CLICK HERE TO SEARCH AVAILABLE HOTEL ACCOMMODATIONS
We encourage attendees who still need accommodations to make their reservations as soon as possible, as availability may become limited as the meeting approaches.
GASCO Registration
Registration is now closed; however, walk-in attendees are welcome. The hotel reservation link will remain available for those who still need overnight accommodations.
CPNG Registration
Cancer Patient Navigators of Georgia (CPNG) Registration
Due to the continued growth of both organizations, Cancer Patient Navigators of Georgia (CPNG) is managing registration for its Navigation & Survivorship Track independently this year. Please use the Eventbrite registration link below to register for the CPNG program. If you plan to attend both the CPNG program and the GASCO Annual Meeting & Best of ASCO®, separate registration is required for each event. If you have previously registered for one or both meetings, please do not register again.
Directions, Floor Plan, and Shipping Information
- Directions to The Hotel at Avalon
- The Hotel at Avalon's Meeting Space Floor Plan
- Exhibitor's Shipping Information
Guidelines & Parameters for Pharmaceutical Industry Poster Presentations
